[go: up one dir, main page]

DK0864645T3 - Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet - Google Patents

Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet

Info

Publication number
DK0864645T3
DK0864645T3 DK96935402T DK96935402T DK0864645T3 DK 0864645 T3 DK0864645 T3 DK 0864645T3 DK 96935402 T DK96935402 T DK 96935402T DK 96935402 T DK96935402 T DK 96935402T DK 0864645 T3 DK0864645 T3 DK 0864645T3
Authority
DK
Denmark
Prior art keywords
stranded rna
virus vector
rna virus
replication activity
negative stranded
Prior art date
Application number
DK96935402T
Other languages
Danish (da)
English (en)
Inventor
Fukashi Murai
Tsuneaki Sakata
Yoshiyuki Nagai
Atsushi Kato
Makoto Asakawa
Mamoru Hasegawa
Tatsuo Shioda
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Application granted granted Critical
Publication of DK0864645T3 publication Critical patent/DK0864645T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18821—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18822—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18841—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18851—Methods of production or purification of viral material
    • C12N2760/18852—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96935402T 1995-10-31 1996-10-22 Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet DK0864645T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30831595 1995-10-31
PCT/JP1996/003068 WO1997016538A1 (fr) 1995-10-31 1996-10-22 Vecteur de virus d'arn a brin negatif possedant une activite de replication autonome

Publications (1)

Publication Number Publication Date
DK0864645T3 true DK0864645T3 (da) 2005-10-24

Family

ID=17979579

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96935402T DK0864645T3 (da) 1995-10-31 1996-10-22 Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet

Country Status (10)

Country Link
US (2) US6723532B2 (zh)
EP (2) EP1325960A3 (zh)
KR (2) KR100754091B1 (zh)
CN (1) CN1118569C (zh)
AT (1) ATE298789T1 (zh)
AU (1) AU7335196A (zh)
DE (1) DE69634904T2 (zh)
DK (1) DK0864645T3 (zh)
HK (1) HK1018287A1 (zh)
WO (1) WO1997016538A1 (zh)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0863202B1 (en) * 1995-11-01 2010-06-09 Dnavec Research Inc. Recombinant sendai virus
CA2336472C (en) * 1998-07-03 2010-08-31 Dnavec Research Inc. Negative-sense rna virus vector for nerve cell
US7241617B2 (en) 1998-07-03 2007-07-10 Dnavec Research, Inc. Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci
US6828138B1 (en) 1998-08-11 2004-12-07 Dnavec Research Inc. Recombinant sendai virus vector including a gene encoding a chemokine
DK1106692T3 (da) * 1998-08-11 2005-10-17 Dnavec Research Inc RNA-virusvektor med kontaktinfiltrationsevne
US6544785B1 (en) 1998-09-14 2003-04-08 Mount Sinai School Of Medicine Of New York University Helper-free rescue of recombinant negative strand RNA viruses
EP1013667B1 (en) * 1998-11-09 2006-10-11 Nippon Biologicals, Inc. Process for preparation of cytokine using a sendai virus expression system
US6490775B1 (en) * 1999-04-23 2002-12-10 Veri-Tek Inc. Press operation verification system
JP3602058B2 (ja) * 1999-05-18 2004-12-15 株式会社ディナベック研究所 エンベロープ遺伝子欠損パラミクソ科ウイルスベクター
US7226786B2 (en) 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
EP1211318B1 (en) * 1999-09-06 2007-08-08 DNAVEC Research, Inc. Paramyxoviruses comprising a modified transcription start sequence
JP4838962B2 (ja) * 1999-11-02 2011-12-14 株式会社ディナベック研究所 気道上皮細胞への外因性遺伝子導入用組換えセンダイウイルスベクター
US7314614B1 (en) 1999-11-02 2008-01-01 Dnavec Research, Inc. Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
WO2001038537A1 (fr) 1999-11-19 2001-05-31 The Kitasato Institute Procede d'elaboration d'un mutant du morbillivirus a fusion cellulaire
KR100774796B1 (ko) * 2000-01-19 2007-11-07 가부시키가이샤 디나벡크 겐큐쇼 파라믹소바이러스 벡터의 혈관으로의 유전자 도입용도
WO2001072340A1 (fr) * 2000-03-30 2001-10-04 Dnavec Research Inc. Vaccin contre le virus du sida, contenant un vecteur du virus de sendai
CA2322057A1 (en) 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
CN100531802C (zh) * 2000-06-01 2009-08-26 株式会社载体研究所 含有血凝素活性膜蛋白质的假型逆转录病毒载体
EP1297852A4 (en) * 2000-06-27 2004-12-29 Dnavec Research Inc VIRAL VECTOR FOR THE INTRODUCTION OF GENES IN KIDNEY CELLS (03.02.03)
AU2001290273A1 (en) * 2000-10-06 2002-04-22 Dnavec Research Inc. Paramyxovirus vector for transferring foreign gene into skeletal muscle
JP2002142770A (ja) 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
EP1344829B1 (en) 2000-11-27 2008-04-23 Dnavec Research Inc. Paramyxovirus vector encoding fibroblast growth factor 2 (fgf2) and use thereof
CN103540568A (zh) 2002-04-26 2014-01-29 米迪缪尼有限公司 制备流感病毒的多质粒系统
US7465456B2 (en) 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
WO2003092738A1 (fr) * 2002-04-30 2003-11-13 Dnavec Research Inc. Composition support de medicament ou de gene avec activite d'hemagglutinine
KR101058294B1 (ko) * 2002-04-30 2011-08-22 가부시키가이샤 디나벡크 겐큐쇼 프로테아제 의존성 트로피즘이 개변된 벡터
US20050191617A1 (en) * 2002-06-03 2005-09-01 Makoto Inoue Pramyxovirusl vectors encoding antibody and utilization thereof
CN1694956A (zh) * 2002-09-04 2005-11-09 株式会社载体研究所 使用衍生自革兰氏阳性菌的唾液酸苷酶产生包含与唾液酸结合的膜蛋白作为包膜成分的病毒载体的方法
US20060104950A1 (en) * 2002-10-24 2006-05-18 Shinji Okano Methods of Tranducing genes into T cells
EP2581093B1 (en) 2003-06-16 2015-03-18 MedImmune, LLC Influenza hemagglutinin and neuraminidase variants
KR20060028432A (ko) * 2003-06-30 2006-03-29 가부시키가이샤 디나벡크 겐큐쇼 고변이영역이 개변된 유전자를 탑재하는 마이너스가닥 ｒｎａ 바이러스 벡터
AU2004286144A1 (en) 2003-11-04 2005-05-12 Dnavec Research Inc. Method for producing gene transferred dendritic cells
ATE469972T1 (de) 2003-12-23 2010-06-15 Medimmune Llc Multiplasmid-system zur erzeugung des grippevirus
CA2553377A1 (en) 2004-01-13 2005-07-28 Dnavec Research Inc. Gene therapy for tumors using minus-strand rna viral vectors encoding immunostimaulatory cytokines
CN1934257A (zh) * 2004-01-22 2007-03-21 株式会社载体研究所 病毒载体的制备方法
KR101279677B1 (ko) 2004-01-22 2013-06-27 가부시키가이샤 디나벡크 겐큐쇼 사이토메갈로바이러스 인핸서 및 닭 β­액틴 프로모터를 포함하는 하이브리드 프로모터를 이용한 마이너스 가닥 ＲＮＡ 바이러스 벡터의 제조방법
WO2005087269A1 (ja) * 2004-03-16 2005-09-22 Dnavec Research Inc. 腫瘍増殖を抑制する方法
JPWO2005097988A1 (ja) * 2004-03-23 2008-02-28 株式会社ディナベック研究所 組織の維持および／または修復に関連する骨髄関連細胞
CA2879182C (en) 2004-05-25 2017-02-14 Medimmune, Inc. Influenza hemagglutinin and neuraminidase variants
JPWO2006001120A1 (ja) * 2004-06-24 2008-04-17 株式会社ディナベック研究所 マイナス鎖ｒｎａウイルスを含む抗癌剤
EP1856271A4 (en) 2005-03-08 2009-11-18 Medimmune Vaccines Inc INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS
US20110162093A1 (en) * 2005-06-14 2011-06-30 Yasuji Ueda Methods for producing antibodies
CN101351557A (zh) * 2005-10-28 2009-01-21 生物载体株式会社 利用以rna病毒或dna病毒的刺突蛋白质假型化的慢病毒载体将基因导入呼吸道上皮干细胞
EP1983048A4 (en) * 2006-01-17 2009-04-22 Dnavec Corp NEW PROTEIN EXPRESSION SYSTEM
CA2654033A1 (en) 2006-05-31 2007-12-06 Dnavec Corporation Therapeutic agent for alzheimer's disease
CN101517079A (zh) 2006-07-13 2009-08-26 生物载体株式会社 非复制型副粘病毒科病毒载体
US7601356B2 (en) 2006-07-21 2009-10-13 Medimmune, Llc Methods and compositions for increasing replication capacity of an influenza virus
CA2659267C (en) 2006-08-09 2016-12-13 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
JPWO2008029790A1 (ja) 2006-09-04 2010-01-21 協和発酵キリン株式会社 新規核酸
EP2123752A4 (en) 2006-12-18 2010-08-11 Kyowa Hakko Kirin Co Ltd NOVEL NUCLEIC ACID
KR20090114431A (ko) 2007-02-07 2009-11-03 디나벡크 가부시키가이샤 약독화 마이너스 가닥 ｒｎａ 바이러스
CA2685417A1 (en) 2007-04-27 2008-11-13 Kyushu University, National University Corporation Viral vector for gene therapy
CA2690196A1 (en) 2007-06-18 2008-12-24 Medimmune, Llc Influenza b viruses having alterations in the hemaglutinin polypeptide
WO2009044899A1 (ja) 2007-10-03 2009-04-09 Kyowa Hakko Kirin Co., Ltd. 細胞の増殖を制御する核酸
WO2009148137A1 (ja) 2008-06-04 2009-12-10 協和発酵キリン株式会社 肥満細胞の脱顆粒を制御する核酸
EP2574344A1 (en) 2008-07-11 2013-04-03 MedImmune, LLC Influenza hemagglutinin and neuraminidase variants
EP2322611B1 (en) 2008-07-16 2016-06-01 IP Pharma Co., Ltd. Method for production of reprogrammed cell using chromosomally unintegrated virus vector
JPWO2010050586A1 (ja) 2008-10-31 2012-03-29 ディナベック株式会社 組み換え蛋白質の発現を増強する方法
SG173642A1 (en) 2009-02-12 2011-09-29 Medimmune Llc Influenza hemagglutinin and neuraminidase variants
EP2522360B1 (en) 2010-01-08 2016-11-16 Kyoto University Vaccine for treatment of tauopathy
US9090909B2 (en) 2010-08-30 2015-07-28 Dnavec Corporation Composition for inducing pluripotent stem cell, and use thereof
DK3050961T5 (da) 2013-09-24 2024-10-14 Id Pharma Co Ltd Fremgangsmåde til forbedring af effektiviteten ved inducering af pluripotente stamceller
JP7150241B2 (ja) 2016-11-17 2022-10-11 国立感染症研究所長 非感染性パラミクソウイルス粒子を用いた感染症ワクチン
EP3656858A4 (en) 2017-07-21 2021-04-21 I'rom Group Co., Ltd. POLYNUCLEOTIDE INTENDED TO MODIFY A TARGET SEQUENCE AND ITS USE
WO2019142933A1 (ja) 2018-01-22 2019-07-25 国立感染症研究所長が代表する日本国 選択的ｃｄ８陽性ｔ細胞誘導ワクチン抗原
US20230220025A1 (en) 2020-09-04 2023-07-13 Heartseed Inc. Quality Improving Agent for IPS Cells, Method of Producing IPS Cells, IPS Cells, and Composition for Producing IPS Cells
IL303975A (en) 2020-12-25 2023-08-01 Univ Kyoto Method for producing naive human ips cells from somatic cells
EP4524249A1 (en) 2022-04-25 2025-03-19 Tokiwa-bio Inc. Rna virus-derived chimeric envelope protein and rna virus vector having same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166057A (en) 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
AU7007491A (en) * 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
JP3029272B2 (ja) 1990-05-29 2000-04-04 邦忠 下遠野 構造蛋白質遺伝子、組換えベクター、組換えウイルス、ポリペプチドおよびポリペプチドの製造方法
US5665362A (en) 1990-09-25 1997-09-09 Cantab Pharmaceuticals Research Limited Viral vaccines
US5318898A (en) 1991-04-02 1994-06-07 Genetics Institute, Inc. Production of recombinant bone-inducing proteins
JPH0585943A (ja) 1991-07-18 1993-04-06 Tonen Corp 組換えワクシニアウイルスを用いる非ａ非ｂ型肝炎ウイルス遺伝子の発現および非ａ非ｂ型肝炎ワクチン
JPH05301895A (ja) 1992-04-22 1993-11-16 Nippon Zeon Co Ltd ハイブリッド抗原タンパク質、それを発現する組み換えウイルス、及びその製造方法
ZA937164B (en) * 1992-09-28 1994-05-23 Commw Scient Ind Res Org Delivery system
US5516720A (en) 1994-02-14 1996-05-14 United Microelectronics Corporation Stress relaxation in dielectric before metallization
ES2210273T5 (es) 1994-07-18 2010-03-29 Conzelmann, Karl-Klaus, Prof. Dr. Virus con arn de cadena negativa no segmentado recombinante infeccioso.
US5716821A (en) 1994-09-30 1998-02-10 Uab Research Foundation Prevention and treatment of respiratory tract disease
US5789229A (en) 1994-09-30 1998-08-04 Uab Research Foundation Stranded RNA virus particles
DK0780475T4 (da) 1995-08-09 2006-10-23 Schweiz Serum & Impfinst Fremgangsmåde til fremstilling af infektiöse negativ-streng RNA-virus
KR0179554B1 (ko) * 1995-11-30 1999-04-15 김주용 반도체 소자의 소자분리절연막 형성방법
EP0906442A1 (en) 1996-05-01 1999-04-07 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins

Also Published As

Publication number Publication date
KR100552387B1 (ko) 2006-04-21
US20020100066A1 (en) 2002-07-25
ATE298789T1 (de) 2005-07-15
EP1325960A3 (en) 2004-09-15
EP0864645A1 (en) 1998-09-16
CN1118569C (zh) 2003-08-20
KR20050084302A (ko) 2005-08-26
EP0864645B1 (en) 2005-06-29
EP1325960A2 (en) 2003-07-09
CN1207123A (zh) 1999-02-03
US6645760B2 (en) 2003-11-11
DE69634904T2 (de) 2006-05-18
HK1018287A1 (en) 1999-12-17
WO1997016538A1 (fr) 1997-05-09
US6723532B2 (en) 2004-04-20
EP0864645B9 (en) 2006-03-22
EP0864645A4 (en) 2000-01-26
KR100754091B1 (ko) 2007-08-31
DE69634904D1 (de) 2005-08-04
KR19990067232A (ko) 1999-08-16
US20020081706A1 (en) 2002-06-27
AU7335196A (en) 1997-05-22

Similar Documents

Publication Publication Date Title
DK0864645T3 (da) Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
DE69638196D1 (de) Rekombinantes sendai-virus
IT8267522A0 (it) Procedimento per la produzione di dna complementare rappresentante sequenze virali di rna mediante metodi del dna ricombinante prodotti relativi e loro usi
DE69828193D1 (de) Hyaluronan synthase gen und seine verwendung
DE69836092D1 (de) Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen
DE69638314D1 (de) Zirkuläres DNA Molekül mit einem abhängigen Replikationsursprung, seine Herstellungsverfahren und seine Verwendung in der Gentherapie
EP0866721A4 (en) TARGET ADENOVIRAL VECTORS
ATE188740T1 (de) Viruspartikel mit veraendertem wirtspektrum
ATE34770T1 (de) Dna-vektoren und ihre verwendung in der rekombinanten dna-technologie.
DK0757717T3 (da) Papillomavirusvacciner
FI871288L (fi) Menetelmä aprotiniinin valmistamiseksi yhdistelmä-DNA-tekniikalla ja menetelmään soveltuva DNA, ilmentämisplasmidi ja isäntäsolu
ATE121452T1 (de) Multifunktionelle rna mit selbstprozessierungsaktivität, ihre herstellung und verwendung.
DE60118798D1 (de) Fragmente der intron a von citomegalovirus
DE69734512D1 (de) Steigerung der genexpression
DE3381566D1 (de) Hepatitis-b-virus-gen enthaltendes rekombinantes plasmid, mit diesem rekombinanten plasmid transformierte hefe und herstellung von hepatitis-b-virus-oberflaechenantigen.
ES509946A0 (es) Un metodo para aumentar la produccion de proteinas por adn heterologo, en vectores de clonacion de plasmidos.
ES8608581A1 (es) Un metodo para la construccion de un gen sintetico para pro-teina objetivo viral
IT8119759A0 (it) Umano, dna e plasmidi che polipeptide prodotto codificano per questa sequenza, microbiologicamente con la sequenza microorganismi che contengono di aminoacidi dell'interferone queste informazioni genetiche e processo per la loro preparazione.
DE3485923D1 (de) Dna-gen, verfahren zu seiner herstellung und dieses gen enthaltendes plasmid.
DE3678702D1 (de) Antitumorprotein-gen von streptococcus pyogenes su, plasmide, die das gen enthalten, transformantenzellen, die die plasmide beherbergen, und verfahren zur herstellung des antitumorproteins.
CA2236113A1 (en) Negative strand rna viral vector having autonomous replication capability
BR9606440A (pt) Processo para classificar neuropatologia dna isolado e purificado polinucleotídeo quimérico vetor de expressão e célula hospedeira
SU903802A1 (ru) Регул тор
DK0817859T3 (da) Rekombinante DNA vektorer til Genterapi
SU702343A1 (ru) Цифровой регул тор